MarketCap
Facebook
X
TelegramQuarterly report 2026-Q1
added 05-23-2026
Fulgent Genetics ROA Ratio 2011-2026 | FLGT
Annual ROA Ratio Fulgent Genetics
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -4.99 | -3.5 | -13.59 | 10.35 | 39.68 | 30.6 | -0.46 | -10.4 | -4.39 | -9.21 | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 39.68 | -13.59 | 3.41 |
Quarterly ROA Ratio Fulgent Genetics
| 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -5.23 | -4.27 | -4.43 | -3.94 | -2.99 | -3.95 | -3.6 | -4.0 | -2.91 | -2.79 | 8.66 | 17.65 | 18.76 | 28.93 | 28.81 | 36.39 | 46.0 | 61.59 | 58.07 | 50.96 | 30.6 | 6.52 | 1.51 | 1.41 | -0.46 | -3.94 | -6.69 | -9.01 | -10.4 | -9.43 | -12.72 | -15.16 | -11.21 | -6.97 | -4.49 | -7.84 | -9.28 | -136.49 | -114.35 | -1.04 | -125.81 | 20.23 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 61.59 | -136.49 | -2.56 |
ROA Ratio of other stocks in the Diagnostics research industry
| Issuer | ROA Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
-51.41 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Heska Corporation
HSKA
|
-3.4 | - | - | $ 1.31 B |  USA |
 |
Agilent Technologies
A
|
11.3 | $ 115.35 | 0.25 % | $ 35.1 B | USA |
 |
Celcuity
CELC
|
-37.95 | $ 133.1 | -0.87 % | $ 6.22 B | USA |
|
Akumin
AKU
|
-8.88 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Co-Diagnostics
CODX
|
-189.54 | $ 6.9 | -24.26 % | $ 9.18 M | USA |
 |
Castle Biosciences
CSTL
|
-4.18 | $ 21.05 | 6.91 % | $ 610 M | USA |
 |
Aspira Women's Health
AWH
|
-0.23 | - | -6.19 % | $ 10.5 M | USA |
 |
Accelerate Diagnostics
AXDX
|
-175.25 | - | -61.36 % | $ 2.46 M | USA |
 |
Biocept
BIOC
|
-103.93 | - | -13.05 % | $ 7.29 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
-0.77 | - | - | $ 562 M |  Britain |
 |
CareDx, Inc
CDNA
|
-5.17 | $ 21.6 | 0.28 % | $ 1.15 B | USA |
 |
Guardant Health
GH
|
-20.67 | $ 125.53 | 4.74 % | $ 15.7 B | USA |
 |
Chembio Diagnostics
CEMI
|
-37.2 | - | 0.22 % | $ 16.8 M | USA |
 |
Check-Cap Ltd.
CHEK
|
55.3 | - | - | $ 9.42 M |  Israel |
 |
HTG Molecular Diagnostics
HTGM
|
-121.47 | - | -20.0 % | $ 1.06 M | USA |
 |
Interpace Biosciences
IDXG
|
72.63 | $ 1.8 | - | $ 7.96 M | USA |
 |
ICON Public Limited Company
ICLR
|
4.69 | $ 116.97 | 2.74 % | $ 9.65 B |  Irlanda |
 |
Illumina
ILMN
|
-19.4 | $ 148.65 | 2.36 % | $ 23.6 B | USA |
 |
Global Cord Blood Corporation
CO
|
5.87 | - | - | $ 399 M |  China |
 |
Fluidigm Corporation
FLDM
|
-16.33 | - | 1.08 % | $ 308 M | USA |
 |
Lantheus Holdings
LNTH
|
10.49 | $ 99.78 | -0.28 % | $ 6.73 B | USA |
 |
Genetic Technologies Limited
GENE
|
-194.25 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-33.12 | - | 0.12 % | $ 80.1 M | China |
 |
DermTech
DMTK
|
-82.74 | - | -11.32 % | $ 2.94 M | USA |
 |
Mettler-Toledo International
MTD
|
23.41 | $ 1 091.39 | -0.9 % | $ 22.5 B |  Schweiz |
 |
Charles River Laboratories International
CRL
|
-2.02 | $ 162.28 | 3.66 % | $ 8.04 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
4.72 | - | - | $ 10.7 B | USA |
 |
NeoGenomics
NEO
|
-7.94 | $ 9.4 | 1.4 % | $ 1.2 B | USA |
 |
Enzo Biochem
ENZ
|
-30.41 | - | -8.98 % | $ 14.8 K | USA |
 |
Medpace Holdings
MEDP
|
22.84 | $ 430.56 | 0.34 % | $ 12.4 B | USA |
 |
National Research Corporation
NRC
|
8.6 | $ 19.07 | 0.13 % | $ 427 M | USA |
 |
Natera
NTRA
|
-39.28 | $ 201.65 | 0.37 % | $ 19.8 B | USA |
 |
Exact Sciences Corporation
EXAS
|
-3.55 | - | - | $ 19.8 B | USA |
 |
Myriad Genetics
MYGN
|
-51.8 | $ 3.89 | 0.91 % | $ 360 M | USA |
 |
Personalis
PSNL
|
-24.32 | $ 9.19 | 2.74 % | $ 820 M | USA |
 |
Koninklijke Philips N.V.
PHG
|
3.33 | $ 26.48 | -1.78 % | $ 25.1 B |  Niderland |
 |
Senseonics Holdings
SENS
|
-54.72 | $ 6.3 | -2.05 % | $ 263 M | USA |
 |
QIAGEN N.V.
QGEN
|
6.76 | - | - | $ 10.6 B | Niderland |
 |
Soleno Therapeutics
SLNO
|
3.71 | - | - | $ 2.69 B | USA |
 |
Biomerica
BMRA
|
-83.65 | $ 2.38 | -3.64 % | $ 5.47 M | USA |
 |
Twist Bioscience Corporation
TWST
|
-12.1 | $ 65.39 | 0.8 % | $ 3.91 B | USA |
 |
Laboratory Corporation of America Holdings
LH
|
4.77 | $ 258.13 | -0.11 % | $ 21.5 B | USA |
 |
Thermo Fisher Scientific
TMO
|
6.08 | $ 448.76 | 0.11 % | $ 169 B | USA |
 |
Waters Corporation
WAT
|
12.66 | $ 340.42 | 0.51 % | $ 20.3 B | USA |
 |
Trinity Biotech plc
TRIB
|
-30.22 | $ 0.67 | 2.95 % | $ 241 M | Irlanda |
 |
Motus GI Holdings
MOTS
|
-178.14 | - | -34.28 % | $ 263 K | Israel |
 |
Neogen Corporation
NEOG
|
-31.71 | $ 9.25 | 1.2 % | $ 2.01 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
6.11 | $ 193.95 | 0.54 % | $ 21.5 B | USA |